Transcriptional activation of human immunodeficiency virus type 1 by herpesvirus infection: An in vivo footprinting study

被引:4
|
作者
Demarchi, F
Bovenzi, P
DiLuca, D
Giacca, M
机构
[1] INT CTR GENET ENGN & BIOTECHNOL,I-34012 TRIESTE,ITALY
[2] UNIV FERRARA,INST MICROBIOL,I-44100 FERRARA,ITALY
关键词
HIV; transcription; in vivo footprinting; long terminal repeat; enhancer; human herpesvirus-6; herpes simplex virus-1; Sp1; nuclear factor-kappa B;
D O I
10.1159/000150523
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The process of transcriptional activation directed by the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) was investigated by in vivo footprinting using ligation-mediated polymerase chain reaction hi a human epithelial cell line infected with. human herpes simplex virus type 1 (HSV-1) or human herpes virus 6 (HHV-6). Infection with both viruses induces a remarkable enhancement in LTR-mediated gene expression that correlates with a change in the pattern of protein binding to the downstream KB Site of the enhancer region. In HHV-6 infected cells, this change in the genomic footprinting pattern is concomitant with the induction of specific enhancer-binding proteins in the nucleus. The similarity of these events to those detected in other previously investigated experimental systems suggests that the LTR enhancer region is the ultimate target for the induction of the HIV-1 transcriptional response upon stimuli acting through different upstream pathways.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 50 条
  • [41] Human immunodeficiency virus type 1 activation after blood transfusion
    Mudido, PM
    Georges, D
    Dorazio, D
    YenLieberman, B
    Bae, S
    OBrien, WA
    Spritzler, J
    Lederman, MM
    TRANSFUSION, 1996, 36 (10) : 860 - 865
  • [42] Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis
    Hashemi, FB
    Ghassemi, M
    Roebuck, KA
    Spear, GT
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04): : 924 - 930
  • [43] Determinants of the natural history of human immunodeficiency virus type 1 infection
    Phair, JP
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S384 - S386
  • [44] Genital infection of female chimpanzees with human immunodeficiency virus type 1
    Girard, M
    Mahoney, J
    Wei, Q
    Van der Ryst, E
    Muchmore, E
    Barré-Sinoussi, F
    Fultz, PN
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (15) : 1357 - 1367
  • [45] P glycoprotein in human immunodeficiency virus type 1 infection and therapy
    Sankatsing, SUC
    Beijnen, JH
    Schinkel, AH
    Lange, JMA
    Prins, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1073 - 1081
  • [46] Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection
    Smith, PD
    Li, L
    Meng, G
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S436 - S440
  • [47] Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1
    Markowitz, Martin
    Grobler, Jay A.
    CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) : 27 - 32
  • [48] Primary infection by type 1 human immunodeficiency virus: Diagnosis and prognosis
    Vanhems, P
    Beaulieu, R
    POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (861) : 403 - 408
  • [49] Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan
    Ho, Ya-Chi
    Shih, Tiffany T. F.
    Lin, Yu-Hui
    Hsiao, Chin-Fu
    Chen, Mao-Yuan
    Hsieh, Szu-Min
    Sheng, Wang-Huei
    Sun, Hsin-Yun
    Hung, Chien-Ching
    Chang, Shan-Chwen
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2007, 60 (06) : 382 - 386
  • [50] Reproduction and fertility in human immunodeficiency virus type-1 infection
    van Leeuwen, E.
    Prins, J. M.
    Jurriaans, S.
    Boer, K.
    Reiss, P.
    Repping, S.
    van der Veen, F.
    HUMAN REPRODUCTION UPDATE, 2007, 13 (02) : 197 - 206